Raheja H, et al. - The efficacy of dual antiplatelet therapy (DAPT) vs single anti-platelet therapy (SAPT) after transcatheter aortic valve replacement (TAVR) was assessed. DAPT failed to prevent stroke, myocardial infarction or death and was associated with a higher risk of bleeding.